Disclosed is a method aiding in the assessment of cancer. It involves the use of the secernin-1 protein (SCRN1) as a universal marker of different cancer types. More specifically disclosed is a method for assessing cancer from a liquid sample derived from an individual by measuring SCRN1 in the sample. Measurement of SCRN1 can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery.
申请公布号
EP2435830(A1)
申请公布日期
2012.04.04
申请号
EP20100722311
申请日期
2010.05.21
申请人
ROCHE DIAGNOSTICS GMBH;F.HOFFMANN-LA ROCHE AG
发明人
WILD, NORBERT;HAGMANN, MARIE-LUISE;KARL, JOHANN;RIEDLINGER, JULIA;ROESSLER, MARKUS;TACKE, MICHAEL